|
IGF2BP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.973200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.005000E-01 |
| Normal-vs-Stage2 |
8.621000E-01 |
| Normal-vs-Stage3 |
1.721820E-01 |
| Normal-vs-Stage4 |
5.484200E-01 |
| Stage1-vs-Stage2 |
3.526200E-01 |
| Stage1-vs-Stage3 |
7.136300E-02 |
| Stage1-vs-Stage4 |
9.203600E-01 |
| Stage2-vs-Stage3 |
2.547000E-01 |
| Stage2-vs-Stage4 |
6.088600E-01 |
| Stage3-vs-Stage4 |
1.440590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.284000E-01 |
| Normal-vs-AfricanAmerican |
2.840400E-01 |
| Normal-vs-Asian |
9.974400E-01 |
| Caucasian-vs-AfricanAmerican |
2.955600E-01 |
| Caucasian-vs-Asian |
9.792000E-01 |
| AfricanAmerican-vs-Asian |
6.777200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.160200E-01 |
| Normal-vs-Female |
7.834000E-01 |
| Male-vs-Female |
9.576000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.427000E-01 |
| Normal-vs-Extreme_Weight |
1.841630E-01 |
| Normal-vs-Obese |
7.969800E-01 |
| Normal-vs-Extreme_Obese |
5.944200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.886400E-01 |
| Normal_Weight-vs-Obese |
3.116800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.984800E-01 |
| Extreme_Weight-vs-Obese |
1.857400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.001800E-01 |
| Obese-vs-Extreme_Obese |
6.641800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.574200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.197600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.382800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.979400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.968400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.234800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.016420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.540800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.963020E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.031200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.054000E-01 |
| Normal-VS-Type2 PRCC |
1.385840E-01 |
| Normal-VS-KIRP CIMP |
7.7524000552387E-09 |
| Normal-VS-Unclassified PRCC |
8.160600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.956500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.63890037494252E-10 |
| Type1 PRCC-VS-Unclassified PRCC |
6.945400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.06070000005509E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
1.487630E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.372840E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.367200E-01 |
| Normal-vs-N1 |
3.783800E-01 |
| Normal-vs-N2 |
3.001200E-01 |
| N0-vs-N1 |
5.084600E-01 |
| N0-vs-N2 |
3.131000E-01 |
| N1-vs-N2 |
3.650600E-01 |
|
|
